Pacer Advisors Inc. Sells 11,600 Shares of Centene Corporation $CNC

Posted by on Aug 10th, 2026

Pacer Advisors Inc. decreased its stake in shares of Centene Corporation (NYSE:CNC – Free Report) by 24.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,093 shares of the company’s stock after selling 11,600 shares during the period. Pacer Advisors Inc.’s holdings in Centene were worth $1,182,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. DV Equities LLC bought a new position in shares of Centene during the 4th quarter valued at $26,000. IFC & Insurance Marketing Inc. bought a new stake in shares of Centene in the fourth quarter worth $28,000. SBI Securities Co. Ltd. lifted its holdings in Centene by 118.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after acquiring an additional 406 shares during the period. Bayban purchased a new position in Centene in the fourth quarter worth about $33,000. Finally, MV Capital Management Inc. bought a new stake in shares of Centene during the 4th quarter valued at about $34,000. Institutional investors own 93.63% of the company’s stock.

Centene Trading Down 0.1%

Shares of Centene stock opened at $65.69 on Monday. Centene Corporation has a fifty-two week low of $25.18 and a fifty-two week high of $69.36. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.15 and a current ratio of 1.15. The company has a market capitalization of $32.45 billion, a P/E ratio of -6.29, a P/E/G ratio of 0.35 and a beta of 1.08. The company has a fifty day moving average of $64.48 and a 200 day moving average of $50.96.

Centene (NYSE:CNC – Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $2.51 EPS for the quarter, beating the consensus estimate of $1.09 by $1.42. The business had revenue of $53.58 billion for the quarter, compared to the consensus estimate of $47.64 billion. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The business’s revenue was up 9.9% on a year-over-year basis. During the same period in the previous year, the business earned ($0.16) earnings per share. Centene has set its FY 2026 guidance at 4.800- EPS. On average, sell-side analysts anticipate that Centene Corporation will post 4.89 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Cantor Fitzgerald increased their price objective on shares of Centene from $60.00 to $75.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 7th. Zacks Research raised shares of Centene from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, July 29th. JPMorgan Chase & Co. raised their target price on Centene from $60.00 to $67.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $40.00 price objective on shares of Centene in a research note on Wednesday, April 29th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $79.00 price objective (up from $68.00) on shares of Centene in a research note on Monday, August 3rd. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $68.58.

Get Our Latest Stock Analysis on Centene

Centene Company Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Featured Stories

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.